News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Venrock Healthcare Capital Partners II, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/14/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/23/2022 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 5% stake in Annexon, Inc. |
| 06/23/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/27/2022 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 5.4% stake in GH Research PLC |
| 05/25/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/23/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/29/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/22/2022 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 10% stake in Lyra Therapeutics, Inc. |
| 04/21/2022 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 10% stake in Trevi Therapeutics, Inc. |
| 02/14/2022 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 6.3% stake in Tricida, Inc. |
| 02/14/2022 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 8.2% stake in Relmada Therapeutics, Inc. |
| 02/14/2022 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 7.5% stake in Aclaris Therapeutics, Inc. |
| 02/14/2022 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 7.3% stake in Aadi Bioscience, Inc. |
| 11/10/2021 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 5.1% stake in LianBio |
| 09/30/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 09/27/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/07/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/15/2021 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 5.4% stake in Instil Bio, Inc. |
| 03/01/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/16/2020 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 5.1% stake in Athira Pharma, Inc. |
| 07/30/2020 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 5.1% stake in IMV Inc. |
| 07/20/2020 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 5% stake in Unum Therapeutics Inc. |
| 06/12/2020 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 8.3% stake in Humanigen, Inc. |
| 06/01/2020 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 19.3% stake in Altimmune, Inc. |
| 05/29/2020 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 9.9% stake in Surface Oncology, Inc. |
| 12/20/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/16/2019 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 6.2% stake in Relmada Therapeutics, Inc. |
| 12/16/2019 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 5.6% stake in IVERIC bio, Inc. |
| 11/25/2019 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 7.3% stake in 89bio, Inc. |
| 11/25/2019 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 10% stake in Sierra Oncology, Inc. |
| 10/07/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/17/2019 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 6.4% stake in Protagonist Therapeutics, Inc. |
| 02/14/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
|
|
|